Associations between asthma and Life’s Essential 8: a cross-sectional study by Jiao Xu, Jianlei Tang

Subjects: Get full text

Facilitators and Solutions for Practicing Optimal Guided Asthma Self-Management: The Physician Perspective by Alexandrine J Lamontagne, Sandra Peláez, Roland Grad, Lucie Blais, Kim L Lavoie, Simon L Bacon, Hélène Guay, Annie Gauthier, Martha L McKinney, Pierre Ernst, Johanne Collin, Francine M Ducharme

“…OBJECTIVE: To identify key solutions that facilitate the prescription of long-term asthma controller and provision of written self-management plans by physicians.…”
Get full text

ADAM Metallopeptidase Domain 33 (ADAM33): A Promising Target for Asthma by Priya Tripathi, Shally Awasthi, Peisong Gao

Get full text

The Utility of Ambulatory pH Monitoring in Patients Presenting with Chronic Cough and Asthma by KF AlHabib, S Vedal, P Champion, JM FitzGerald

“…OBJECTIVE: To evaluate the prevalence of gastroesophageal reflux disease (GERD) in patients presenting with asthma and chronic cough.…”
Get full text

IL-17 Is a Key Regulator of Mucin-Galectin-3 Interactions in Asthma by Manoj J. Mammen, Jamil Ali, Amita Aurora, Umesh C. Sharma, Ravikumar Aalinkeel, Supriya D. Mahajan, Mark Sands, Stanley A. Schwartz

“…We previously showed that the absence of tissue inhibitor of metalloproteinase 1 (TIMP-1) enhances lung inflammation, airway hyperreactivity, and lung remodeling in asthma in an ovalbumin (OVA) asthma model of TIMP-1 knockout (TIMPKO) mice as compared to wild-type (WT) controls and mediated by increased galectin-3 (Gal-3) levels. …”
Get full text

Peripheral blood miRNAs are associated with airflow below threshold in children with asthma by Anshul Tiwari, Brian D. Hobbs, Rinku Sharma, Jiang Li, Alvin T. Kho, Sami Amr, Juan C. Celedón, Scott T. Weiss, Craig P. Hersh, Kelan G. Tantisira, Michael J. McGeachie

Subjects: Get full text

Association between bronchial asthma severity, control level and life quality in children by Alexander Torres Molina

“…<p><strong>Foundation</strong>: bronchial asthma is one of the most prevalent chronic diseases in childhood. …”
Get full text

Clinical, Epidemiological and Therapeutic Characteristics of Patients Admitted for a Bronchial Asthma Attack by Juan Carlos Yanes Macías, Juan Camilo Díaz Ceballos, Mercedes Fonseca Hernández, Ileana García Rodríguez, Caridad Llul Tombo, Daimy Tio González

“…<strong>Background:</strong> bronchial asthma is the prevalent chronic non-communicable disease in childhood, in its evolution it presents crises triggered by multiple factors, related to the host and the environment. …”
Get full text

The Role of RSV Infection in Asthma Initiation and Progression: Findings in a Mouse Model by Junyan Han, Katsuyuki Takeda, Erwin W. Gelfand

“…The findings shed light on the mechanisms underlying the association between early severe RSV infection and development of asthma later in childhood.…”
Get full text

Prevalence and risk factors for childhood asthma: a systematic review and meta-analysis by Weijun Zhou, Jia Tang

Subjects: Get full text

Investigating the Status of Physical Activity, Adherence to Treatment, and Quality of Life in Individuals with Asthma by Soheila Rabie Siahkali, Mojghan Sadat Aghvamy, Mohammad Javad Naghihoo

Subjects: Get full text

Modifications of the maximum expiratory flow in bronchial asthma treatment using Intal and Ketotifeno. by Belkis M. Vicente Sánchez, Nallelys Villanueva Bravo, Luis M. Padrón Velásquez, Marylin Aroche Quintana

“…<strong>Introduction</strong>: The studies of the lung function are essential for the diagnosis, classification and treatment of the Bronchial Asthma and inside them the mensuration of the flow maximum expiratory (FEM) it provides a quantitative value of the obstruction of the air roads. …”
Get full text

Is immunotherapy protective against steroid intake in patients with polysensitized allergic rhinitis and/or asthma? by Feridun Gürlek

Subjects: Get full text

Association of Corticosteroid Inhaler Type with Saliva Microbiome in Moderate-to-Severe Pediatric Asthma by Amir Hossein Alizadeh Bahmani, Mahmoud I. Abdel-Aziz, Simone Hashimoto, Corinna Bang, Susanne Brandstetter, Paula Corcuera-Elosegui, Andre Franke, Mario Gorenjak, Susanne Harner, Parastoo Kheiroddin, Leyre López-Fernández, Anne H. Neerincx, Maria Pino-Yanes, Uroš Potočnik, Olaia Sardón-Prado, Antoaneta A. Toncheva, Christine Wolff, Michael Kabesch, Aletta D. Kraneveld, Susanne J. H. Vijverberg, Anke H. Maitland-van der Zee, on behalf of the SysPharmPediA consortium

Subjects: “…asthma…”
Get full text

A Comparison of Work-Exacerbated Asthma Cases from Clinical and Epidemiological Settings by Paul K Henneberger, Xiaoming Liang, Catherine Lemière

“…BACKGROUND: Clinical and epidemiological studies commonly use different case definitions in different settings when investigating work-exacerbated asthma (WEA). These differences are likely to impact characteristics of the resulting WEA cases.…”
Get full text

Relationship between prognostic nutritional index and asthma: a cross-sectional analysis by Zhimeng Jiang, Zhimeng Jiang, Xingyu Zhu, Xingyu Zhu, Huixin Jiang, Donglin Zhao, Donglin Zhao, Jianwei Tian

Subjects: Get full text

Recent advances in research on common targets of neurological and sex hormonal influences on asthma by Wenting Zhou, Huan Chen, Xinyu Chen, Jing Gao, Wenting Ji

Subjects: “…asthma…”
Get full text

The Effects of Nebulized Inhaled Triptolide on Airway Inflammation in a Mouse Model of Asthma by Yafang Miao, Li Wei, Hao Chen, Zeming Zhang, Li Han

“…Here, we intend to investigate the effect of nebulized inhaled TP on airway inflammation in a mouse model of asthma. 29 SPF BALB/c mice were divided into four groups: blank control (Blk, n = 5), normal saline (NS, n = 8), dexamethasone (Dex, n = 8), and TP (n = 8). …”
Get full text

Cellular and cytokine immunoregulation in patients with chronic obstructive pulmonary disease and bronchial asthma by Wanda Stankiewicz, Marek P. Dabrowski, Andrzej Chcialowski, Tadeusz Plusa

“…In addition to diverse effector mechanisms, the cellular and humoral elements participating in the development of immune response may appear to be different in COPD and bronchial asthma (BA) patients.…”
Get full text

Comparison of Once- with Twice-Daily Dosing of Fluticasone Propionate in Mild and Moderate Asthma by Louis-Philippe Boulet, Robert L Cowie, Roberto Dal Negro, Wade Brett, Milton Gold, Agostinho Marques, William S Thorburn, Nate M Stepner, Reid Bobson

“…OBJECTIVES: Two 12-week, randomized, double-blind, parallel-group studies were performed to compare the efficacy and safety of once- and twice-daily dosing of fluticasone propionate (FP) in the treatment of mild to moderate asthma, considered to require the equivalent of either 200 or 500 µg of FP daily.…”
Get full text